1-5 of 5
Jose A. Cancelas
Close
Sort by
Journal Articles

Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant

Jeremy D. Rubinstein, Carolyn Lutzko, Thomas Leemhuis, Xiang Zhu, Giang Pham, Lorraine Ray, Shawn Thomas, Celeste Dourson, Jamie Wilhelm, Adam Lane, Jose A. Cancelas, Dakota Lipps, Justin Ferrell, Patrick J. Hanley, Michael D. Keller, Catherine M. Bollard, YunZu M. Wang, Stella M. Davies, Adam S. Nelson, Michael S. Grimley
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2897–2907.
https://doi.org/10.1182/bloodadvances.2021006309
Published: 2022
Journal Articles

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Thomas Leemhuis, Giang Pham, Lorraine Ray, Sana Emberesh, Sonata Jodele, Shawn Thomas, Jose A. Cancelas, Catherine M. Bollard, Patrick J. Hanley, Michael D. Keller, Olivia Grimley, Diana Clark, Teri Clark, Cecilia S. Lindestam Arlehamn, Alessandro Sette, Stella M. Davies, Adam S. Nelson, Michael S. Grimley, Carolyn Lutzko
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3309–3321.
https://doi.org/10.1182/bloodadvances.2021004456
Published: 2021
Includes: Supplemental data
Journal Articles

Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients

Adam S. Nelson, Daria Heyenbruch, Jeremy D. Rubinstein, Anthony Sabulski, Sonata Jodele, Shawn Thomas, Carolyn Lutzko, Xiang Zhu, Thomas Leemhuis, Jose A. Cancelas, Michael Keller, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael S. Grimley
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5745–5754.
https://doi.org/10.1182/bloodadvances.2020003073
Published: 2020
Includes: Supplemental data
Journal Articles

FOXO activity adaptation safeguards the hematopoietic stem cell compartment in hyperglycemia

Vinothini Govindarajah, Jung-Mi Lee, Michael Solomon, Bryan Goddard, Ramesh Nayak, Kalpana Nattamai, Hartmut Geiger, Nathan Salomonis, Jose A. Cancelas, Damien Reynaud
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5512–5526.
https://doi.org/10.1182/bloodadvances.2020001826
Published: 2020
Includes: Supplemental data
Journal Articles

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Carolyn Lutzko, Tom Leemhuis, Jose A. Cancelas, Sonata Jodele, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael S. Grimley, Adam S. Nelson
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3252–3257.
https://doi.org/10.1182/bloodadvances.2020002252
Published: 2020